Jamie Christensen - 16 Dec 2021 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 18:10:04 UTC
Previous filing
07 Dec 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +19,149 +32% $0.000000 78,742 16 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 25% of the PSUs will vest on December 16, 2022, the one-year anniversary of the Achievement Date, and then 25% annually for the next 3 years, subject to Dr. Christensen's continuous service.
F2 Includes 88 shares acquired under the ESPP Purchase on 11/30/2021